No Data
Renascience: Confirmation letter
Renascience: Half Year Report - Term 26 (2024/04/01 - 2025/03/31)
Renascience: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Asahi, Matsukiyo, Dentsu Group, Lancers (14th) (1379-4990)
※The above calendar is merely a schedule and may be subject to change due to the company's circumstances. --------------------------------------- November 14 (Thursday) <1379> Hokuto <1380> Akikawa Bokuen <142A> Jinjibu <1438> Gifu Landscape <1443> Giken HD <1446> Candiule <1447> SAAF HD <145A> El
Renascience, stem inc rim and others
Upward revision, the previous operating profit forecast 0.063 billion yen ← 0.025 billion yen.
Stocks that moved the previous day part2 Money Forward, Dai Communications, Bank of Inove, etc.
Stock name <code> 22nd closing price ⇒ previous day comparison Peptide Dream <4587> 2842.5 -125.5 Stock price reaching the 3000 yen range also enhances the sense of achievement. Rakuten Bank <5838> 3110 -165 On the 22nd, bank stocks also experienced almost universal declines. Fujitsu General <6755> 1959.5 -80.5 Earnings reports approaching etc are also seen as cautionary factors. MonotaRO <3064> 2354 -103.5 Strong movements on the 21st due to movements such as raising the target stock price.
No Data
No Data